DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Aktueller Standort:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Paul Scherrer Institute utilizing Varian Eclipse for IMPT proton treatment planning

Varian-equipped Emory proton therapy center opens

Radiation therapy’s pivotal role in treating breast cancer featured at SABCS 2018

Accuray CyberKnife System treatment delivery times up to 50 percent faster with software upgrade

Hygeia Hospital adopts RTsafe technology to enhance patient-specific safety in brain cancer radiotherapy

HollandPTC opens with ProBeam from Varian

Varian Halcyon receives China NMPA approval

MSH selects seven Varian linear accelerators to expand treatment capabilities across South Africa

Boston Scientific announces recommended offer to acquire BTG plc.

Narita Memorial Proton Center, Japan, treats first patient with the treatment planning system RayStation

IBA receives marketing authorization for ProteusONE in Brazil

Press releases may be edited for formatting or style
Louvain-la-Neuve, Belgium, September 18th, 2018, IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it has received marketing authorization from the Brazilian Health Regulatory Agency (ANVISA) for its single-room proton therapy solution Proteus®ONE*.

Proteus®ONE, IBA's single-room proton therapy system is smaller, less expensive, faster to install and includes the latest advances in targeted proton therapy technologies, including IBA's truly compact Image Guided Intensity Modulated Proton Therapy (IG-IMPT). The Proteus®ONE has a unique open gantry environment that is easy for radiation therapists to work in and optimizes the patient experience by providing a comfortable environment.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



IBA created Proteus®ONE to allow more patients access to proton therapy globally and has already sold 24 Proteus®ONE systems worldwide. The powerful combination of smaller system size, clinical capabilities and patient-centered design is the reason why Proteus®ONE is being adopted by so many advanced institutions around the world.

Olivier Legrain, Chief Executive Officer of IBA commented: "We are delighted to have received marketing authorization from ANVISA which we expect to increase interest in our Proteus®ONE* in the region. This is also an exciting milestone for our potential customers in Brazil, where the cost of healthcare is a major focus. Much smaller and more affordable than conventional multi-room proton therapy systems, but with the same clinical applications, Proteus®ONE makes proton therapy more accessible both to clinical institutions worldwide and to their cancer patients. With more than 30 years of experience, IBA has designed and installed the majority of clinically operating proton therapy centers in the world and this most recent approval from ANVISA reaffirms our world leading position in the delivery of highly targeted, safer cancer treatment solutions."


About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.

Back to HCB News
  Pages: 1

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED